Equecabtagene autoleucel produced “remarkable” responses in patients whose disease progressed after prior BCMA CAR T-cell therapy, researchers reported.
Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients with cancer, according to new research led by scientists at the ...
This raises concerns about unnecessary treatment toxicity and patient quality of life in cases unlikely to derive survival benefit. Reference: Daskivich TJ et al. Overtreatment of prostate cancer ...
This study was also published today in JAMA pediatrics. Funding for this study was provided by a project grant from the Canadian Institutes of Health Research and the National Institutes of Health.
This study was also published today in JAMA pediatrics. Funding for this study was provided by a project grant from the Canadian Institutes of Health Research and the National Institutes of Health.